AAAAAA

   
Results: 1-7 |
Results: 7
CD5 NEGATIVE B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - CLINICAL AND BIOLOGICAL FEATURES OF 42 CASES
Authors: CARTRON G LINASSIER C BREMOND JL DESABLENS B GEORGET MT FIMBEL B LUTHIER F DUTEL JL LAMAGNERE JP COLOMBAT P
Citation: G. Cartron et al., CD5 NEGATIVE B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - CLINICAL AND BIOLOGICAL FEATURES OF 42 CASES, Leukemia & lymphoma, 31(1-2), 1998, pp. 209-216
FIRST LINE HIGH-DOSE CHEMOTHERAPY WITH PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ADVANCED CLL (BINET STAGE B-C) - RESULTS OF A PROSPECTIVE PHASE-II STUDY
Authors: LINASSIER C CAHN JY DESABLENS B SENSEBE L VILQUE JP WITZ F COMBE M LUTHIER F DECONNINCK E MALIVOIR B COLOMBAT P
Citation: C. Linassier et al., FIRST LINE HIGH-DOSE CHEMOTHERAPY WITH PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ADVANCED CLL (BINET STAGE B-C) - RESULTS OF A PROSPECTIVE PHASE-II STUDY, Bone marrow transplantation, 21, 1998, pp. 269-269
PROGNOSTIC FACTORS AND SURVIVAL IN ELDERLY PATIENTS WITH MULTIPLE-MYELOMA
Authors: RODON P GAUVAIN JB LINASSIER C BENBOUBKER L LEVALLOIS D MAIGRE M GOUPILLE P LUTHIER F LUCAS V DUGAY J COLOMBAT P
Citation: P. Rodon et al., PROGNOSTIC FACTORS AND SURVIVAL IN ELDERLY PATIENTS WITH MULTIPLE-MYELOMA, British Journal of Haematology, 102(1), 1998, pp. 354-354
MULTIPLE-MYELOMA IN ELDERLY PATIENTS - A STUDY OF SURVIVAL, PROGNOSTIC FACTORS AND RESPONSE TO TREATMENT
Authors: RODON P GAUVAIN JB LINASSIER C LUTHIER F MAIGRE M GOUPILLE P CUSSON P LUCAS V DUGAY J ALLAIS C COLOMBAT P
Citation: P. Rodon et al., MULTIPLE-MYELOMA IN ELDERLY PATIENTS - A STUDY OF SURVIVAL, PROGNOSTIC FACTORS AND RESPONSE TO TREATMENT, Blood, 90(10), 1997, pp. 4108-4108
FIRST LINE HIGH-DOSE CHEMOTHERAPY WITH PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ADVANCED CLL (BINET STAGE B-C) - RESULTS OF A PROSPECTIVE PHASE-II STUDY
Authors: LINASSIER C CAHN JY DESABLENS B SENESEBE L VILQUE JP WITZ F COMBE M LUTHIER F DECONNINCK E MALIVOIR B COLOMBAT P
Citation: C. Linassier et al., FIRST LINE HIGH-DOSE CHEMOTHERAPY WITH PURGED AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ADVANCED CLL (BINET STAGE B-C) - RESULTS OF A PROSPECTIVE PHASE-II STUDY, Blood, 90(10), 1997, pp. 1030-1030
VAD-PECC REGIMEN IN THE TREATMENT OF ADVANCED-STAGE MULTIPLE-MYELOMA
Authors: DELAIN M LINASSIER C PETITDIDIER C GOUPILLE P LUTHIER F COMBE M REISENLEITER M BENBOUBKER L LAMAGNERE JP COLOMBAT P
Citation: M. Delain et al., VAD-PECC REGIMEN IN THE TREATMENT OF ADVANCED-STAGE MULTIPLE-MYELOMA, Journal of clinical oncology, 12(12), 1994, pp. 2706-2713
CASE OF ASSOCIATION BETWEEN HEPATOCELLULAR-CARCINOMA AND PORPHYRIA VARIEGATA
Authors: GERMANAUD J LUTHIER F CAUSSE X KERDRAON R GROSSETTI D GARGOT D NORDMANN Y
Citation: J. Germanaud et al., CASE OF ASSOCIATION BETWEEN HEPATOCELLULAR-CARCINOMA AND PORPHYRIA VARIEGATA, Scandinavian journal of gastroenterology, 29(7), 1994, pp. 671-672
Risultati: 1-7 |